One-year outcome and its prediction in first-episode schizophrenia - A naturalistic study

Psychopathology

Volumn 41, Issue 2, 2007, Pages 115-123

  Bachmann, Silke ^a   Bottmer, Christina ^b   Schröder, Johannes ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Compliance with atypical antipsychotics; Gender; Prediction of 1 year outcome; Schizophrenia, first episode

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENPERIDOL; CHLORPROMAZINE; CLOZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HUMAN; MALE; NATURALISTIC INQUIRY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PROGNOSIS; RATING SCALE; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE; STRAUSS CARPENTER SCALE; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUESTIONNAIRES; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 37349039462     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112027     Document Type: Article

References (80)

1. Bleuler M: Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Stuttgart, Thieme, 1972, p 513.
2. Huber G, Gross G, Schuettler R: Schizophrenia. Clinical course and social psychiatric long-term examinations of schizophrenic patients hospitalized in Bonn from 1945 to 1959. Monogr Gesamtgeb Psychiatr Psychiatry Ser 1979;21:1-399.
3. Ciompi L, Medvecka J: Comparative study of long-term mortality in the mentally ill. Schweiz Arch Neurol Neurochir Psychiatr 1976;118:111-135.
4. Harding CM: Course types in schizophrenia: an analysis of European and American studies. Schizophr Bull 1988;14:633-643.
5. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A: The Vermont longitudinal study of persons with severe mental illness. I. Methodology, study sample, and overall status 32 years later. Am J Psychiatry 1987;144:718-726.
6. Marneros A, Deister A, Rohde A: Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr Scand 1990;82:352-358.
7. Marneros A, Steinmeyer EM, Deister A, Rohde A, Junemann H: Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III. Social consequences. Eur Arch Psychiatry Neurol Sci 1989;238:135-139.
8. Helgason L: Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr Scand 1990;81:231-235.
9. Breier A, Schreiber JL, Dyer J, Pickar D: National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-246.
10. Carone BJ, Harrow M, Westermeyer JF: Posthospital course and outcome in schizophrenia. Arch Gen Psychiatry 1991;48:247-253.
11. Carpenter WT Jr, Strauss JS: The prediction of outcome in schizophrenia. 4. Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517-525.
12. Johnstone EC, Frith CD, Crow TJ, Owens DG, Done DJ, Baldwin EJ, Charlette A: The Northwick Park 'Functional' Psychosis Study: diagnosis and outcome. Psychol Med 1992;22:331-346.
13. Geddes J, Mercer G, Frith CD, MacMillan F, Owens DG, Johnstone EC: Prediction of outcome following a first episode of schizophrenia. A follow-up study of Northwick Park first episode study subjects. Br J Psychiatry 1994;165:664-668.
14. Harrison G, Mason P, Glazebrook C, Medley I, Croudace T, Docherty S: Residence of incident cohort of psychotic patients after 13 years of follow-up. BMJ 1994;308:813-816.
15. DeSisto M, Harding CM, McCormick RV, Ashikaga T, Brooks GW: The Maine and Vermont three-decade studies of serious mental illness. II. Longitudinal course comparisons. Br J Psychiatry 1995;167:338-342.
16. Mason P, Harrison G, Glazebrook C, Medley I, Dalkin T, Croudace T: Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 1995;167:596-603.
17. Sartorius N, Gulbinat W, Harrison G, Laska E, Siegel C: Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol 1996;31:249-258.
18. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R: Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 1986;16:909-928.
19. Leon CA: Clinical course and outcome of schizophrenia in Cali, Colombia. A 10-year follow-up study. J Nerv Ment Dis 1989;177:593-606.
20. Davidson L, McGlashan TH: The varied outcomes of schizophrenia. Can J Psychiatry 1997;42:34-43.
21. Larsen TK, McGlashan TH, Johannessen JO, Friis S, Guldberg C, Haahr U, Horneland M, Melle I, Moe LC, Opjordsmoen S, Simonsen E, Vaglum P: Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry 2001;158:1917-1919.
22. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T: Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004;61:143-150.
23. Angst J: European long-term follow-up studies of schizophrenia. Schizophr Bull 1988;14:501-513.
24. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G: One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994;151:1409-1416.
25. Sartorius N, Jablensky A, Shapiro R: Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychol Med 1977;7:529-541.
26. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A: Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992;20:1-97.
27. Haefner H, an der Heiden W: Course and outcome of schizophrenia; in Hirsch SR, Weinberger DR (eds): Schizophrenia, ed 2. Oxford, Blackwell Science, 2003, pp 101-141.
28. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, et al: Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001;178:506-517.
29. Harrison G, Amin S, Singh SP, Croudace T, Jones P: Outcome of psychosis in people of African-Caribbean family origin. Population-based first-episode study. Br J Psychiatry 1999;175:43-49.
30. Leff JP, Hirsch SR, Gaind R, Rhode PD, Stevens BC: Life events and maintenance therapy in schizophrenic relapse. Br J Psychiatry 1973;123:659-660.
31. Gift TE, Strauss JS, Harder DW, Kokes RF, Ritzler BA: Established chronicity of psychotic symptoms in first-admission schizophrenic patients. Am J Psychiatry 1981;138:779-784.
32. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR: Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-1188.
33. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I: Predicting the long-term outcome of schizophrenia. Psychol Med 1996;26:697-705.
34. Lieberman JA, Koreen AR, Chakos M, Sheitman B, Woerner M, Alvir JM, Bilder R: Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 1996;57(suppl 9):5-9.
35. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC: A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986;148:120-127.
36. May P, Tuma AH: Treatment of schizophrenia: an experimental study of five treatment methods. Br J Psychiatry 1965;111:503-510.
37. Waddington J: The clinical psychopharmacology of antipsychotic drugs in schizophrenia; in Hirsch SR, Weinberger DR (eds): Schizophrenia. Oxford, Blackwell, 1995, pp 341-357.
38. Meltzer HY: Outcome in schizophrenia: beyond symptom reduction. J Clin Psychiatry 1999;60(suppl 3):3-8.
39. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M: SKID-I. Strukturiertes klinisches Interview für DSM-IV. Göttingen, Hogrefe, 1997.
40. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
41. Strauss JS, Carpenter WT Jr: The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry 1974;31:37-42.
42. Simpson GM, Angus JW: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;212:11-19.
43. Barnes TR: A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676.
44. National Institute of Mental Health: Abnormal Involuntary Movement Scale (AIMS); in Guy WE (ed): Early Clinical Drug Evaluation Unit Assessment. Rockville, Department of Health and Human Services, 1976, pp 266-268.
45. American Psychiatric Association: Diagnostic and Statistic Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
46. Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P, Wooff K: Long-term course of hospitalization for schizophrenia. I. Risk for rehospitalization. Schizophr Bull 1992;18:217-228.
47. McGlashan TH: Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry Suppl 1998;172:3-6.
48. Gupta S, Andreasen NC, Arndt S, Flaum M, Hubbard WC, Ziebell S: The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients. Schizophr Res 1997;23:1-13.
49. Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC: Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001;47:215-222.
50. Malla AK, Norman RM, Takhar J, Manchanda R, Townsend L, Scholten D, Haricharan R: Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? J Nerv Ment Dis 2004;192:455-463.
51. Bachmann S, Bottmer C, Schroeder J: Neurological soft signs in first-episode schizophrenia - A follow-up study. Am J Psychiatry 2005;162:1-7.
52. Johnstone EC, Frith CD, Gold A, Stevens M: The outcome of severe acute schizophrenic illnesses after one year. Br J Psychiatry 1979;134:28-33.
53. McCreadie RG, Wiles D, Grant S, Crockett GT, Mahmood Z, Livingston MG, Watt JA, Greene JG, Kershaw PW, Todd NA, et al: The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group. Acta Psychiatr Scand 1989;80:597-602.
54. Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M: Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-376.
55. Rabiner CJ, Wegner JT, Kane JM: Outcome study of first-episode psychosis. I. Relapse rates after 1 year. Am J Psychiatry 1986;143:1155-1158.
56. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N: Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000;157:60-66.
57. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO: Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000;45:1-9.
58. Shepherd M, Watt D, Falloon I, Smeeton N: The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Suppl 1989;15:1-46.
59. Leary J, Johnstone EC, Owens DG: Social outcome. Br J Psychiatry Suppl 1991;13:13-20, 44-46.
60. May PR, Tuma AH, Dixon WJ, Yale C, Thiele DA, Kraude WH: Schizophrenia. A follow-up study of the results of five forms of treatment. Arch Gen Psychiatry 1981;38:776-784.
61. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241-247.
62. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE: The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull 1992;18:185-207.
63. Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999;156:544-549.
64. Keshavan MS, Schooler NR: First-episode studies in schizophrenia: criteria and characterization. Schizophr Bull 1992;18:491-513.
65. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A: Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001;58:148-157.
66. Coryell W, Tsuang MT: DSM-III schizophreniform disorder. Comparisons with schizophrenia and affective disorder. Arch Gen Psychiatry 1982;39:66-69.
67. Fenton WS: Course and outcome in schizophrenia. Curr Opin Psychiatry 1997;10:40-44.
68. Fenton WS, McGlashan TH: Sustained remission in drug-free schizophrenic patients. Am J Psychiatry 1987;144:1306-1309.
69. Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ: Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 1990;157:182-189.
70. Haas GL, Sweeney JA: Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992;18:373-386.
71. Beiser M, Erickson D, Fleming JA, Iacono WG: Establishing the onset of psychotic illness. Am J Psychiatry 1993;150:1349-1354.
72. Haas GL, Garratt LS, Sweeney JA: Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998;32:151-159.
73. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161:473-479.
74. Johnstone EC, Crow TJ, Johnson AL, MacMillan JF: The Northwick Park Study of first episodes of schizophrenia. 1. Presentation of the illness and problems relating to admission. Br J Psychiatry 1986;148:115-120.
75. McGlashan TH: The prediction of outcome in chronic schizophrenia. 4. The Chestnut Lodge follow-up study. Arch Gen Psychiatry 1986;43:167-176.
76. Vazquez-Barquero J, Cuesta Nunez MJ, Herrera Castanedo S, Diez Manrique JF, Pardo G, Dunn G: Sociodemographic and clinical variables as predictors of the diagnostic characteristics of first episodes of schizophrenia. Acta Psychiatr Scand 1996;94:149-155.
77. Angermeyer MC, Kuehn L: Gender differences in age at onset of schizophrenia. An overview. Eur Arch Psychiatry Neurol Sci 1988;237:351-364.
78. Bleuler E: Lehrbuch der Psychiatrie. Berlin, Springer, 1979.
79. Zarate CJ, Tohen M, Land M: First-episode schizophreniform disorder: comparisons with first-episode schizophrenia. Schizophr Res 2000;46:31-34.
80. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441-449.